Expand TPST Menu
TPST MENU

TPST Stock Posts


TPST #TempestTherapeutics stock declines -12.6% in premarket,

Premarket Decliner

TPST Tempest Therapeutics8.88-0.07-0.8%

Premarket:7.76-1.12 (-12.6%)

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

Globe NewswireWed, 11-Jun 8:00 AM
Unusual Option Volume

TPST Tempest Therapeutics1.29+0.12 (+10.3%)

Tempest Therapeutics trades 3,628 contracts.
View Details...
Unusual Option Volume

TPST Tempest Therapeutics1.87+0.68 (+57.1%)

Tempest Therapeutics trades 2,371 contracts. News: Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
View Details...
TPST #TempestTherapeutics stock increases 39.6% after hours.

After Hours Gainer

TPST Tempest Therapeutics2.85-0.06-2.1%

After Hours:3.98+1.13 (+39.7%)

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

Globe NewswireTue, 18-Jun 6:22 PM
TPST #TempestTherapeutics stock increases 39.6% after hours.

After Hours Gainer

TPST Tempest Therapeutics2.85-0.06-2.1%

After Hours:3.98+1.13 (+39.7%)

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

Globe NewswireTue, 18-Jun 6:22 PM
Unusual Option Volume

TPST Tempest Therapeutics4.98-0.46 (-8.5%)

Tempest Therapeutics trades 2,752 contracts. The company has the following event: American Association for Cancer Research (AACR) Annual Meeting on Apr 8, 2024.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes